TELESIS BIO
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TELESIS BIO and buy or sell other stocks, ETFs, and their options commission-free!About TBIO
Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction.
CEORonald C. Renaud, Jr., MBA
CEORonald C. Renaud, Jr., MBA
Employees—
Employees—
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2011
Founded2011
Employees—
Employees—
TBIO Key Statistics
Market cap2.82B
Market cap2.82B
Price-Earnings ratio74.36
Price-Earnings ratio74.36
Dividend yield—
Dividend yield—
Average volume1.07M
Average volume1.07M
High today$0.021
High today$0.021
Low today$0.021
Low today$0.021
Open price$0.021
Open price$0.021
Volume167.00
Volume167.00
52 Week high$37.99
52 Week high$37.99
52 Week low$0.021
52 Week low$0.021
Stock Snapshot
The current TELESIS BIO(TBIO) stock price is $0.02, with a market capitalization of 2.82B. The stock trades at a price-to-earnings (P/E) ratio of 74.36.
On 2025-11-16, TELESIS BIO(TBIO) stock moved within a range of $0.02 to $0.02. With shares now at $0.02, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 167, compared to an average daily volume of 1.07M.
The stock's 52-week range extends from a low of $0.02 to a high of $37.99.
The stock's 52-week range extends from a low of $0.02 to a high of $37.99.